These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 9829574)
41. Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease. Bocti C; Rockel C; Roy P; Gao F; Black SE Dement Geriatr Cogn Disord; 2006; 21(5-6):364-72. PubMed ID: 16534206 [TBL] [Abstract][Full Text] [Related]
42. FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Foster NL; Heidebrink JL; Clark CM; Jagust WJ; Arnold SE; Barbas NR; DeCarli CS; Turner RS; Koeppe RA; Higdon R; Minoshima S Brain; 2007 Oct; 130(Pt 10):2616-35. PubMed ID: 17704526 [TBL] [Abstract][Full Text] [Related]
43. Usefulness of measurement of the temporal stem on magnetic resonance imaging in the diagnosis of frontotemporal dementia. Hayashida Y; Hirai T; Korogi Y; Kimura T; Ishizuka K; Kawanaka K; Yamura M; Kitajima M; Ikushima I; Yamashita Y Acta Radiol; 2006 Jul; 47(6):603-8. PubMed ID: 16875340 [TBL] [Abstract][Full Text] [Related]
44. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. Piert M; Koeppe RA; Giordani B; Berent S; Kuhl DE J Nucl Med; 1996 Feb; 37(2):201-8. PubMed ID: 8667045 [TBL] [Abstract][Full Text] [Related]
45. [Cerebral glucose metabolism in dementia (PET-FDG study)]. Hatazawa J; Itoh M; Matsuzawa T Rinsho Hoshasen; 1989 Oct; 34(11):1343-8. PubMed ID: 2601096 [TBL] [Abstract][Full Text] [Related]
46. [Change of cerebral metabolism rate of glucose of cerebral white matter in Alzheimer's disease: a study with statistical parametric mapping software]. Cao QY; Guo WH; Yang HL; Shen DW; Zhao P; Jiang KD; Zhang MY; Xiao SF Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2777-9. PubMed ID: 18167271 [TBL] [Abstract][Full Text] [Related]
47. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445 [TBL] [Abstract][Full Text] [Related]
48. Cortical glucose metabolism in psychiatric wandering patients with vascular dementia. Meguro K; Yamaguchi S; Yamazaki H; Itoh M; Yamaguchi T; Matsui H; Sasaki H Psychiatry Res; 1996 May; 67(1):71-80. PubMed ID: 8797244 [TBL] [Abstract][Full Text] [Related]
49. Brain fluorodeoxyglucose (FDG) PET in dementia. Kato T; Inui Y; Nakamura A; Ito K Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244 [TBL] [Abstract][Full Text] [Related]
50. Positron emission tomography in Alzheimer's disease. Duara R; Grady C; Haxby J; Sundaram M; Cutler NR; Heston L; Moore A; Schlageter N; Larson S; Rapoport SI Neurology; 1986 Jul; 36(7):879-87. PubMed ID: 3487046 [TBL] [Abstract][Full Text] [Related]
51. Frontotemporal dementia and Alzheimer disease: evaluation of cortical atrophy with automated hemispheric surface display generated with MR images. Kitagaki H; Mori E; Yamaji S; Ishii K; Hirono N; Kobashi S; Hata Y Radiology; 1998 Aug; 208(2):431-9. PubMed ID: 9680572 [TBL] [Abstract][Full Text] [Related]
52. Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project. Ishii H; Ishikawa H; Meguro K; Tashiro M; Yamaguchi S Int Psychogeriatr; 2009 Feb; 21(1):148-56. PubMed ID: 19040787 [TBL] [Abstract][Full Text] [Related]